Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Carcinoma, Renal Cell 7Kidney Neoplasms 4Prostatic Neoplasms 3Adenocarcinoma 2Neoplasm Metastasis 1

Interventions

Docetaxel 292Prednisone 241enzalutamide 195Leuprolide 185Radiotherapy 179Abiraterone Acetate 170Magnetic Resonance Spectroscopy 163bicalutamide 141Goserelin 138Androgen Antagonists 121acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108Radiosurgery 108apalutamide 93abiraterone 83gallium 68 PSMA-11 81Specimen Handling 73darolutamide 67Surveys and Questionnaires 64Gonadotropin-Releasing Hormone 63Triptorelin Pamoate 58Radiation 57Biopsy 57Brachytherapy 54cabazitaxel 53Standard of Care 51Radiotherapy, Intensity-Modulated 51Zoledronic Acid 50pembrolizumab 49luprolide acetate gel depot 49Flutamide 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Radiofrequency Ablation × Genitourinary × Clear all
NCT07237399 2026-05-13

TA-P-OLIM

University Hospital, Ghent

Withdrawn
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT02328807 2021-08-06

Focal Prostate Radio-Frequency Ablation

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
6 enrolled 7 charts
Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT01423006 2013-11-14

Pilot Study on Focal Prostate Radio-Frequency Ablation

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
5 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡